Back

Progression of atrioventricular valve regurgitation in patients with and without atrial fibrillation

12 April 2026 (17:27 - 17:39)
Organised by: Logo
Congress Presentation Part of: Congenital heart disease and channelopathies Clinical EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Mr Michael Benjamin Koechlin

Cardiovascular Research Institute Basel, Basel (Switzerland)

4 More presentations in this session

Presentation thumbnail
Gene therapy for catecholaminergic polymorphic ventricular tachycardia (CPVT): IND-enabling data and design of the ARTEMIS Phase 1b clinical trial
Doctor A. Farzaneh-Far (Boston, US)
Abstract Slides Video
Presentation thumbnail
Atrioventricular junction ablation in patients with congenital heart disease: a multicenter study on procedural characteristics and outcomes
Mr N. Ramdat Misier (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Phenotypic heterogeneity in Andersen-Tawil syndrome: Insights from the International ATS Registry
Mrs P. Bhardwaj (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Genetic variability in Andersen-Tawil syndrome: insights from the international ATS Registry
Doctor S. Jacobsen (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Congenital heart disease and channelopathies
Video

The Event

Event poster

EHRA 2026

12 April 2026 17:27 CET
You may be interested in
thumbnail
Congress Presentation
A decade of follow-up: atrial fibrillation, pulmonary pressure, and the progression of tricuspid regurgitation
thumbnail
Congress Presentation
Mitral and tricuspid regurgitation in patients with atrial fibrillation
thumbnail
Congress Presentation
Impact of atrial fibrillation on progression of tricuspid regurgitation in patients undergoing transcatheter aortic valve replacement

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources